Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000714872 | SCV000845618 | uncertain significance | not specified | 2018-08-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002532983 | SCV003514231 | uncertain significance | Multiple mitochondrial dysfunctions syndrome 3; Hereditary spastic paraplegia 74 | 2021-12-21 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 102 of the IBA57 protein (p.Val102Gly). This variant is present in population databases (rs759005478, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with IBA57-related conditions. ClinVar contains an entry for this variant (Variation ID: 587628). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |